diffuse lung disease final - cloudcme3/16/2015 26 summary • cystic lung disease • lch: upper...
TRANSCRIPT
-
3/16/2015
1
Jitesh Ahuja, MD
DIFFUSE LUNG DISEASERESIDENT REVIEW COURSE 2015
UNIVERSITY OF WASHINGTON, SEATTLE
INTRODUCTION
• Interstitial lung disease• Cystic lung disease• Vasculitis• Infection • Neoplastic • Miscellaneous
-
3/16/2015
2
APPROACH
Distribution
Pattern
Associated abnormalities
Clinical information
PATTERN
Reticular
Nodular
Cystic
GGO/consolidation
-
3/16/2015
3
SECONDARY PULMONARY LOBULE
RETICULATION
-
3/16/2015
4
TRACTION BRONCHIECTASIS AND HONEYCOMBING
NODULAR
Perilymphatic Centrilobular
-
3/16/2015
5
40-YEAR-OLD MAN WITH COUGH AND SOBWHAT IS THE DIAGNOSIS?
a. Lymphangioleiomyomatosis (LAM)
b. Langerhans cell histiocytosis (LCH)
c. Centrilobular emphysema
d. Cystic fibrosis
LANGERHANS CELL HISTIOCYTOSIS (LCH)
-
3/16/2015
6
• Almost exclusively in adult smokers• Diagnosis with history and CT
LANGERHANS CELL HISTIOCYTOSIS (LCH)
CENTRILOBULAR EMPHYSEMA
-
3/16/2015
7
Exclusively women, 20-40 years
LYMPHANGIOLEIOMYOMATOSIS (LAM)
Sporadic or tuberous sclerosis complex (TSC)
• Recurrent pneumothorax, chylothorax, centrilobular nodules (pneumocyte or muscle cell hyperplasia), GGO (pulmonary hemorrhage), septal thickening
• Vascular endothelial growth factor (VEGF-D) elevated (>800pg/ml)
LYMPHANGIOLEIOMYOMATOSIS (LAM)
-
3/16/2015
8
LYMPHOCYTIC INTERSTITIAL PNEUMONIA (LIP)
Sjögren's syndrome
LYMPHOCYTIC INTERSTITIAL PNEUMONIA (LIP)
• Interstitial lung disease
• Within the spectrum of lymphoproliferative disorders
• Polyclonal or monoclonal gammopathy
• F>M; 4thto5th decade
• Autoimmune disease: Sjögren's syndrome, SLE, RA
• 1/4th reported cases have Sjögren's syndrome
• HIV (pediatric)
• Common variable immunodeficiency (CVID)
-
3/16/2015
9
BIRT-HOGG-DUBE SYNDROME
Skin lesions
• AD, mutation of gene encoding tumor suppressor protein “folliculin”
• Clinical manifestations• Skin lesions such as fibrofolliculomas
face, neck and upper back
• Renal tumors (oncocytoma or RCC)
• Pneumothorax 33-38% patients
BIRT-HOGG-DUBE SYNDROME
-
3/16/2015
10
LCH LAM
LIP Birt-Hogg-Dube
50-YEAR-OLD MALE WITH COUGH AND SOB FOR 2 YEARSWHICH OF THE FOLLOWING IS TRUE?
a. Predominant abnormality is ground glass opacity
b. Predominant abnormality is reticulation
c. There is no honeycombingd. There is no apicobasilar
disease gradient
-
3/16/2015
11
• UIP pattern• Subpleural and basilar
predominant
• Reticular abnormality
• Honeycombing with or without traction bronchiectasis
• Absence of features which are inconsistent with UIP
• Possible UIP• Subpleural and basilar
predominant
• Reticular abnormality
• Honeycombing with or without traction bronchiectasis
• Absence of features which are inconsistent with UIP
USUAL INTERSTITIAL PNEUMONIA (UIP)
INCONSISTENT WITH UIP
• Upper and mid lung predominance
• Peribronchovascular pattern
• Extensive ground glass opacity (GGO>reticulation)
• Profuse micronodules
• Discrete cysts
• Diffuse mosaic attenuation/air-trapping
• Consolidation
-
3/16/2015
12
USUAL INTERSTITIAL PNEUMONIA (UIP)
USUAL INTERSTITIAL PNEUMONIA (UIP)
• Idiopathic pulmonary fibrosis (IPF)- when idiopathic
• Collagen vascular disease (RA, SS), drugs (bleomycin), occupational or environmental exposure (asbestosis)
• Poor prognosis: median survival 2 to 4 years• Definite UIP pattern on HRCT does not need
confirmation by histology
-
3/16/2015
13
POSSIBLE UIP
NON SPECIFIC INTERSTITIAL PNEUMONIA (NSIP)
Dermatopolymyositis
-
3/16/2015
14
NON SPECIFIC INTERSTITIAL PNEUMONIA (NSIP)
NON SPECIFIC INTERSTITIAL PNEUMONIA (NSIP)
• Idiopathic or associated with collagen vascular disease (polymyositis, scleroderma, mixed connective tissue disorder), drug toxicity, occupational exposure
• Cellular or fibrotic• Prognosis much better than UIP
-
3/16/2015
15
SUBACUTE HYPERSENSITIVITY PNEUMONITIS
Exposure to birds
CHRONIC HYPERSENSITIVITY PNEUMONITIS
-
3/16/2015
16
HYPERSENSITIVITY PNEUMONITIS
• Farmer’s lung and bird fancier’s lung • Immunologically-mediated diffuse
granulomatous lung disease
• Aspergillus and thermophilic actinomycesare common inciting agents
• Removal of offending agent can prevent development of fibrosis
DESQUAMATIVE INTERSTITIAL PNEUMONIA
Chronic smoker
-
3/16/2015
17
CRYPTOGENIC ORGANIZING PNEUMONIA
No white countNo symptoms of infection
ORGANIZING PNEUMONIA
• Inflammatory response to pulmonary insult.
• Idiopathic: cryptogenic organizing pneumonia (COP)
• Secondary: connective tissue diseases, infections, malignancies, drugs, radiation, organ/stem cell transplantation and aspiration
• Reverse halo or Atoll sign
-
3/16/2015
18
a. Perilymphatic distribution of nodules
b. Centrilobular distribution of nodules
c. Lymphadenopathy is uncommon
d. Peripheral and basal predominant pattern
40-YEAR-OLD FEMALE WITH COUGH AND SOB FOR >6 MONTHS. WHICH OF THE FOLLOWING IS CORRECT ABOUT THIS DISEASE?
SARCOIDOSIS
-
3/16/2015
19
SARCOIDOSIS
Lymphadenopathy Galaxy sign
SARCOIDOSIS
Progressive massive fibrosis (PMF) Air trapping
-
3/16/2015
20
• Multisystem chronic granulomatous disease of unknown etiology
• African-American females• Thoracic involvement
90% cases• ~50% asymptomatic• 20% progress to
pulmonary fibrosis
SARCOIDOSIS
40-YEAR-OLD MALE WITH COUGH AND DYSPNEA WHICH OF THE FOLLOWING IS FALSE ABOUT THIS DISEASE?
a. Intraalveolar proteinaceousmaterial
b. Associated with hematologic malignancies
c. No association with smoking
d. Treatment is whole lung lavage
-
3/16/2015
21
PULMONARY ALVEOLAR PROTIENOSIS
Crazy paving
PULMONARY ALVEOLAR PROTIENOSIS
• Intraalveolar accumulation of proteinaceous material• Impaired surfactant homeostasis• Idiopathic (>90%) or secondary• Antibodies to GM-CSF• Secondary: hematologic malignancies, infections,
immunodeficiency including HIV or immunosuppressive drugs
• Strong association with smoking• Treatment: whole lung lavage and curing primary cause
-
3/16/2015
22
DIFFUSE ALVEOLAR HEMORRHAGE
Hemoptysis, SOB, no feverNo fluid overloadMicroscopic polyangitis
• Blood filling up the alveolar spaces
• Hemoptysis, anemia, radiographic pulmonary opacities and hypoxic respiratory failure
• Hemoptysis is absent in 1/3rd of cases
• Vasculitis, infections, coagulation disorders, leukemia, stem cell transplantation, crack lung, drug toxicity
• BAL helps in making the diagnosis but not underlying cause
DIFFUSE ALVEOLAR HEMORRHAGE
-
3/16/2015
23
PNEUMOCYSTIS PNEUMONIA
Fever and SOB with hypoxiaHIVCD4 count
-
3/16/2015
24
54-YEAR-OLD MALE WITH SOBWHAT IS THE DIAGNOSIS?
a. Pulmonary edemab. Ca lung with lymphangitic
carcinomatosisc. Hypersensitivity pneumonitisd. Sarcoidosis
LYMPHANGITIC CARCINOMATOSIS
-
3/16/2015
25
LYMPHANGITIC CARCINOMATOSIS
• Usually with carcinoma of lung, breast, stomach, colon, pancreas
• Hematogenous dissemination or direct invasions of lymphatics from mediastinal or hilar LN
• Unilateral/bilateral; focal or diffuse• Poor prognosis
PULMONARY EDEMA
-
3/16/2015
26
SUMMARY
• Cystic lung disease• LCH: upper lobes bizarre shaped cysts, CLN in
young smoker• LAM: uniform randomly distributed cysts in
women ± TSC• LIP: perivascular cysts• Birt-Hogg-Dube: Lenticular cysts with renal
tumors, skin lesions
SUMMARY
• ILD• UIP: honeycombing, heterogeneity• NSIP: GGO, subpleural sparing, homogeneity• COP: Peribronchovascular and subpleural
distribution
• Sarcoidosis: perilymphatic nodules • Crazy-paving: PAP, DAH, pulmonary edema,
infections, adenocarcinoma